Mitogen	O
-	O
activated	O
protein	O
kinase	O
kinase	O
signaling	O
promotes	O
growth	O
and	O
vascularization	O
of	O
fibrosarcoma	B-Cancer
.	O

We	O
hypothesized	O
that	O
signaling	O
through	O
multiple	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
kinase	O
(	O
MKK	O
)	O
pathways	O
is	O
essential	O
for	O
the	O
growth	O
and	O
vascularization	O
of	O
soft	B-Cancer
-	I-Cancer
tissue	I-Cancer
sarcomas	I-Cancer
,	O
which	O
are	O
malignant	B-Cancer
tumors	I-Cancer
derived	O
from	O
mesenchymal	B-Tissue
tissues	I-Tissue
.	O

We	O
tested	O
this	O
using	O
HT	B-Cell
-	I-Cell
1080	I-Cell
,	O
NCI	B-Cell
,	O
and	O
Shac	B-Cell
fibrosarcoma	I-Cell
-	I-Cell
derived	I-Cell
cell	I-Cell
lines	I-Cell
and	O
anthrax	O
lethal	O
toxin	O
(	O
LeTx	O
)	O
,	O
a	O
bacterial	O
toxin	O
that	O
inactivates	O
MKKs	O
.	O

Western	O
blots	O
confirmed	O
that	O
LeTx	O
treatment	O
reduced	O
the	O
levels	O
of	O
phosphorylated	O
extracellular	O
signal	O
-	O
regulated	O
kinase	O
and	O
p38	O
MAPK	O
in	O
vitro	O
.	O

Although	O
short	O
treatments	O
with	O
LeTx	O
only	O
modestly	O
affected	O
cell	B-Cell
proliferation	O
,	O
sustained	O
treatment	O
markedly	O
reduced	O
cell	B-Cell
numbers	O
.	O

LeTx	O
also	O
substantially	O
inhibited	O
the	O
extracellular	B-Immaterial_anatomical_entity
release	O
of	O
angioproliferative	O
factors	O
including	O
vascular	O
endothelial	O
growth	O
factor	O
,	O
interleukin	O
-	O
8	O
,	O
and	O
basic	O
fibroblast	O
growth	O
factor	O
.	O

Similar	O
results	O
were	O
obtained	O
with	O
cell	B-Cell
lines	I-Cell
derived	O
from	O
malignant	B-Cancer
fibrous	I-Cancer
histiocytomas	I-Cancer
,	O
leiomyosarcomas	B-Cancer
,	O
and	O
liposarcomas	B-Cancer
.	O

In	O
vivo	O
,	O
LeTx	O
decreased	O
MAPK	O
activity	O
and	O
blocked	O
fibrosarcoma	B-Cancer
growth	O
.	O

Growth	O
inhibition	O
correlated	O
with	O
decreased	O
cellular	B-Cell
proliferation	O
and	O
extensive	O
necrosis	O
,	O
and	O
it	O
was	O
accompanied	O
by	O
a	O
decrease	O
in	O
tumor	B-Cancer
mean	O
vessel	B-Multi-tissue_structure
density	O
as	O
well	O
as	O
a	O
reduction	O
in	O
serum	B-Organism_substance
expression	O
of	O
angioproliferative	O
cytokines	O
.	O

Vital	O
imaging	O
using	O
high	O
-	O
resolution	O
ultrasound	O
enhanced	O
with	O
contrast	O
microbubbles	O
revealed	O
that	O
the	O
effects	O
of	O
LeTx	O
on	O
tumor	B-Cancer
perfusion	O
were	O
remarkably	O
rapid	O
(	O
less	O
than	O
24	O
h	O
)	O
and	O
resulted	O
in	O
a	O
marked	O
reduction	O
of	O
perfusion	O
within	O
the	O
tumor	B-Cancer
but	O
not	O
in	O
nontumor	B-Tissue
tissues	I-Tissue
.	O

These	O
results	O
are	O
consistent	O
with	O
our	O
initial	O
hypothesis	O
and	O
lead	O
us	O
to	O
propose	O
that	O
MKK	O
inhibition	O
by	O
LeTx	O
is	O
a	O
broadly	O
effective	O
strategy	O
for	O
targeting	O
neovascularization	O
in	O
fibrosarcomas	B-Cancer
and	O
other	O
similar	O
proliferative	B-Cancer
lesions	I-Cancer
.	O

